Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy in hypertension.

F H Messerli1

  • 1Department of Internal Medicine, Ochsner Clinic, New Orleans, Louisiana 70121.

Journal of Human Hypertension
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urocortin 2 - a protective effect in hypertension?

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023
Same author

In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.

International journal of cardiology·2021
Same author

More SPRINT controversy.

Journal of internal medicine·2017
Same author

Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?

Hipertension y riesgo vascular·2015
Same author

Cardioprotection with beta-blockers: myths, facts and Pascal's wager.

Journal of internal medicine·2009
Same author

Beta-blockers as fourth-line therapy for hypertension: stay the course.

International journal of clinical practice·2009
Same journal

Mindfulness based interventions for blood pressure reduction: systematic and umbrella review of existing meta-analyses.

Journal of human hypertension·2026
Same journal

Invasive observation of reactive systolic blood pressure responses to upper-arm cuff inflation.

Journal of human hypertension·2026
Same journal

Association between post-thrombectomy blood pressure trajectories and clinical outcomes in hypertensive patients with acute ischemic stroke: a retrospective cohort study.

Journal of human hypertension·2026
Same journal

Systemic inflammation indices generated from first-trimester blood tests can be potential biomarkers for predicting preeclampsia.

Journal of human hypertension·2026
Same journal

Chronotherapy in hypertension: a systematic review and meta-analysis of antihypertensive dosing timing on cardiovascular outcomes.

Journal of human hypertension·2026
Same journal

Effect of relative handgrip strength and back muscle strength on the incidence of hypertension: 18-year follow-up in a population-based cohort study.

Journal of human hypertension·2026
See all related articles

Combining angiotensin converting enzyme (ACE) inhibitors and calcium antagonists offers additive benefits for blood pressure control, heart health, and kidney protection. Further research is needed to confirm if these improvements reduce patient mortality and morbidity.

Area of Science:

  • Cardiology
  • Pharmacology
  • Nephrology

Background:

  • Monotherapy often fails to control hypertension, necessitating combination therapy.
  • Common antihypertensive combinations include beta-blockers with diuretics, ACE inhibitors with diuretics, beta-blockers with calcium antagonists, and ACE inhibitors with calcium antagonists.
  • ACE inhibitors and calcium antagonists are of particular interest due to their metabolic inertness and target organ protective effects.

Purpose of the Study:

  • To evaluate the combined effects of ACE inhibitors and calcium antagonists in hypertension management.
  • To explore the pathophysiologic changes associated with this specific drug combination.
  • To determine if combination therapy translates to reduced morbidity and mortality.

Main Methods:

Related Experiment Videos

  • Review of current clinical practices and pharmacological data.
  • Analysis of additive effects on antihypertensive efficacy.
  • Assessment of impacts on left ventricular hypertrophy and renal circulation.

    • Main Results:

    • Combination therapy demonstrates additive effects on lowering blood pressure.
    • This combination shows benefits in reducing left ventricular hypertrophy.
    • Renal circulation protection is observed with combined ACE inhibitors and calcium antagonists.

    Conclusions:

    • ACE inhibitors and calcium antagonists provide synergistic antihypertensive effects.
    • The combination favorably impacts target organ damage, including the heart and kidneys.
    • Clinical outcomes regarding morbidity and mortality require further investigation to validate these pathophysiologic benefits.